Stock Research: Integral Diagnostics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Integral Diagnostics

ASX:IDX AU000000IDX2
63
  • Value
    6
  • Growth
    95
  • Safety
    Safety
    55
  • Combined
    57
  • Sentiment
    68
  • 360° View
    360° View
    63
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Integral Diagnostics Limited is an Australia-based provider of medical imaging services. It operates in diagnostic imaging services through brands like Lake Imaging, The X-Ray Group, South Coast Radiology, Peloton Radiology, Imaging Queensland, Apex Radiology, Astra Radiology, SRG Radiology, Horizon Radiology, and Trinity MRI. The company operates across four Australian States: Victoria, New South Wales, Queensland, and Western Australia, and also in New Zealand. In the last fiscal year, the company had 1977 employees, a market cap of $645 million, profits of $298 million, and revenue of $313 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock Integral Diagnostics are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Integral Diagnostics. The consolidated Value Rank has an attractive rank of 55, which means that the share price of Integral Diagnostics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 55% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 68. But the company’s financing is risky with a Safety rank of 6. This means 94% of comparable companies have a safer financing structure than Integral Diagnostics. ...read more

more
Index
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 57 91 55
Growth
95 100 29 45
Safety
Safety
6 6 10 6
Sentiment
68 69 34 80
360° View
360° View
63 71 17 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
100 89 69 73
Opinions Change
58 47 44 50
Pro Holdings
n/a 53 53 70
Market Pulse
40 42 13 52
Sentiment
68 69 34 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 57 91 55
Growth
95 100 29 45
Safety Safety
6 6 10 6
Combined
57 50 23 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
41 44 54 47
Price vs. Earnings (P/E)
65 63 79 57
Price vs. Book (P/B)
52 40 71 45
Dividend Yield
74 78 86 68
Value
55 57 91 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
49 92 47 65
Profit Growth
84 96 45 23
Capital Growth
93 89 60 34
Stock Returns
71 87 7 67
Growth
95 100 29 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
13 9 10 4
Refinancing
10 12 10 14
Liquidity
14 16 20 19
Safety Safety
6 6 10 6

Similar Stocks

Discover high‑ranked alternatives to Integral Diagnostics and broaden your portfolio horizons.

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Suncorp

ASX:SUN
Country: Australia
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

Flight Centre Travel

ASX:FLT
Country: Australia
Industry: Hotels, Resorts & Cruise Lines
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.